Laure Ory-Lavollée
Profile
Laure Ory-Lavollée, who worked at Diatos SA and Cellectis SA, was a director at both firms.
She also worked as an analyst at Puilaetco in 2002.
Former positions of Laure Ory-Lavollée
| Companies | Position | End |
|---|---|---|
Diatos SA
 Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Director/Board Member | 2009-09-14 |
| Puilaetco | Analyst-Equity | 2002-05-14 |
| CELLECTIS S.A. | Director/Board Member | - |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| CELLECTIS S.A. | Health Technology |
| Private companies | 2 |
|---|---|
Diatos SA
Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Health Technology |
| Puilaetco | Finance |
- Stock Market
- Insiders
- Laure Ory-Lavollée
